Replies to post #28558 on Relief Therapeutics Holding AG (RLFTF)

[aGuyUS]

Look at this paper's last two pages and you will see that Dex has been used with VIP in the Lancet Paper in 19 out of the 21 patients

"Rapid Recovery from COVID-19 Respiratory Failure with comorbidity in 21 patients treated with Vasoactive Intestinal Peptide"

https://poseidon01.ssrn.com/delivery.php?ID=087089099092099126006024114004123005050043040037001065095116120016040016023004081009048058064018121010121102106002014124076065086080004018003103018002022031021043016064026115014047090033098002050015019071040049022012127026083095064009002078076104100096108000027099103075127009029114123102009&EXT=pdf